Progress of autologous hematopoietic stem cell transplantation for malignant lymphoma treatment / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 765-768, 2017.
Article
en Zh
| WPRIM
| ID: wpr-664151
Biblioteca responsable:
WPRO
ABSTRACT
Autologous hematopoietic stem cell transplantation (AHSCT) is an important method for treatment of malignant lymphoma. Its treatment process is relatively complex, and the curative effect can be affected by many factors. AHSCT has been widely applied in different subtypes of ML treatment, and looking for effective prognostic factors to further differentiate patients who may benefit from AHSCT and formulating reasonable transplantation are important issues for the clinical doctors to deal with. This article briefly reviews the clinical progress of AHSCT for ML treatment.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2017
Tipo del documento:
Article